reference/35437296

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35437296

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	0892-6638 1530-6860
issueIdentifier	4
pageRange	e22840-
publicationName	FASEB journal : official publication of the Federation of American Societies for Experimental Biology
startingPage	e22840
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Li X, Li Y, Liu B, Chen L, Lyu F, Zhang P, He Q, Cheng L, Liu C, Song Y, Xing Y. P4HA2‐mediated HIF‐1α stabilization promotes erdafitinib‐resistance in FGFR3‐alteration bladder cancer. The FASEB Journal. 2023 Mar 21;37(4). doi: 10.1096/fj.202201247r.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65a409ef3106c5c946177c24b5b343b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6892a457b4f5c0efb505b6ebaa35f88a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f83abd658e5ec2f5e2fc8db44ec34b82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19214a26c8b420de46ca26e52de6b904 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd8eabb83fc7eafe3d96fe8edb0ae617 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffe21c93402f5bc46607fd1af9121424 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b106b11caa6f4668b1caf1c42f2c059 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_110d388801307d7ca483c536f9af1e26 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc47defd1e3605f746f02d29fe8a4b3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cd5339f03ce03b97336d306489a3dc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e5d116dc7dbc4c2a8902e2e3cf16878
date	2023-03-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36943397 https://doi.org/10.1096/fj.202201247r
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3815 https://portal.issn.org/resource/ISSN/1530-6860 https://portal.issn.org/resource/ISSN/0892-6638
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	P4HA2‐mediated HIF‐1α stabilization promotes erdafitinib‐resistance in FGFR3‐alteration bladder cancer
discusses	http://id.nlm.nih.gov/mesh/M0026397 http://id.nlm.nih.gov/mesh/M0474913 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0473626 http://id.nlm.nih.gov/mesh/M0197390 http://id.nlm.nih.gov/mesh/M000614131 http://id.nlm.nih.gov/mesh/M000597435
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002295Q000188 http://id.nlm.nih.gov/mesh/D002295Q000235 http://id.nlm.nih.gov/mesh/D001749Q000473 http://id.nlm.nih.gov/mesh/D001749Q000188 http://id.nlm.nih.gov/mesh/D002295Q000473 http://id.nlm.nih.gov/mesh/D001749Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017382 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D051498Q000235 http://id.nlm.nih.gov/mesh/D011720Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67462786 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d4cb671d20806caaf5644afb03f6746 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8c075e30e34529f0e70ff46783a8bbdd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_106c8f7eb09546f02d46a1d20b67582f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2261 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3091 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_001156685 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8974 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_000133

Showing number of triples: 1 to 60 of 60.